Related Experiment Video
Updated: May 8, 2026

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents
Published on: June 6, 2018
Lead acetate may cause erectile dysfunction by modulating NO/cGMP pathway in rat corpus cavernosum
1Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Azarita, P. Box: 21521, Alexandria, Egypt, senbelamira@yahoo.com.
Lead exposure significantly impairs erectile function in rats by increasing oxidative stress and reducing nitric oxide availability. This study highlights lead
Area of Science:
- Toxicology
- Urology
- Reproductive Medicine
Background:
- Metal toxicity is a known health concern, yet lead's specific impact on erectile function remains under-investigated.
- Understanding the mechanisms of lead-induced erectile dysfunction is crucial for public health.
Purpose of the Study:
- To investigate the effects of lead acetate exposure on erectile function in a rat model.
- To explore the potential mechanisms underlying lead's impact on the erectile process.
Main Methods:
- Rats received daily intraperitoneal injections of lead acetate for 21 days.
- Erectile function was assessed by measuring intracavernosal pressure/mean arterial pressure (ICP/MAP) following nerve stimulation.
- Biochemical markers including oxidative stress indicators (malonaldehyde, reduced glutathione, superoxide dismutase), nitrite/nitrate levels, creatinine, urea, and testosterone were analyzed in various tissues.
- Acute intravenous lead acetate administration was also performed to assess immediate effects on neurogenic erections.
Main Results:
- Subacute lead acetate treatment significantly reduced erectile function.
- This impairment was associated with elevated malonaldehyde and reduced nitrite/nitrate levels in the corpus cavernosum.
- Acute lead administration dose-dependently inhibited neurogenic erections, an effect modulated by nitric oxide pathway inhibitors and antioxidants.
Conclusions:
- Lead acetate exposure negatively impacts erectile function in rats.
- Lead's prooxidant effects, nitric oxide inactivation, and potential modulation of guanylate cyclase and potassium channels contribute to erectile dysfunction.
Related Concept Videos
Nitric Oxide Signaling Pathway
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Male Sexual Response: Erection & Ejaculation
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...